Company / PP&E per Share
Corvus Pharmaceuticals, Inc. PP&E per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2024
5-year range
$0.00 / $0.03
FY2020-FY2024
Trend
-49.6%
vs FY2023
Sector context
#180 of 193
Health Care
What the data says
Among 193 Health Care companies, Corvus Pharmaceuticals, Inc. is in the bottom 7% for pp&e per share. PP&E per Share has declined for 9 consecutive years, from $4.94 in FY2015 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -45.1%.
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -38.8%
- 5-Year CAGR
- -45.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 193This company $0.00 Sector average $18.71
▼
-100.0% below sector average
Key checks
Key Insights
- Corvus Pharmaceuticals, Inc.'s pp&e per share has declined for 9 consecutive years.
- In FY2024, pp&e per share decreased 49.6% year-over-year.
- Ranks #180 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -49.6% |
| FY2023 | $0.00 | -35.2% |
| FY2022 | $0.01 | -29.6% |
| FY2021 | $0.01 | -64.9% |
| FY2020 | $0.03 | -38.3% |
| FY2019 | $0.05 | -37.1% |
| FY2018 | $0.08 | -39.2% |
| FY2017 | $0.13 | -38.1% |
| FY2016 | $0.21 | -95.7% |
| FY2015 | $4.94 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026